<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02382133</url>
  </required_header>
  <id_info>
    <org_study_id>201408123</org_study_id>
    <nct_id>NCT02382133</nct_id>
  </id_info>
  <brief_title>Comparison of Nasal and Forehead Oximetry in Critically Ill Patients at Risk for Decreased Peripheral Perfusion</brief_title>
  <official_title>Comparison of Nasal and Forehead Oximetry in Critically Ill Patients at Risk for Decreased Peripheral Perfusion</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Washington University School of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Continuous pulse oximetry monitoring is the standard of care in critically ill patients in
      emergency departments, operating rooms and intensive care units. In patients with poor
      peripheral perfusion (low blood flow) due to peripheral vascular disease, low body
      temperature, or shock and the use of medications to raise the blood pressure, clinicians have
      difficulty obtaining an accurate measurement. This study compares the accuracy of forehead
      oximetry sensors to nasal alar sensors to lab oximetry measures and on the rate of device
      related pressure ulcers with both.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Continuous pulse oximetry monitoring is the standard of care in critically ill patients in
      emergency departments, operating rooms and intensive care units. In patients with poor
      peripheral perfusion (low blood flow) due to peripheral vascular disease, low body
      temperature, or shock and the use of medications to raise the blood pressure, clinicians have
      difficulty obtaining an accurate measurement. Several studies have demonstrated the utility
      of forehead sensor measurements under these clinical conditions. Forehead sensor measurement
      is considered to be a more central measurement than with digit or ear sensors. However the
      sensor requires a head band for accurate measurement. On a regular basis, the forehead sensor
      has led to pressure ulcer development at Barnes-Jewish Hospital despite following vendor
      recommendations for alternating placement every 8 hours from one side of the forehead to the
      other. An alternate sensor placed on the nose has recently demonstrated rapid detection of
      induced drops in oxygen saturation. It has also demonstrated correlation with arterial oxygen
      saturation measured in a clinical laboratory. The oxygen saturation measurement from the nose
      is also considered a central measurement. However, studies of the nose sensor were conducted
      in healthy subjects or during anesthesia care over several hours. Therefore, research is
      needed to examine the accuracy of the nose sensor in the ICU patient population. In addition,
      due to concerns for sensor related pressure ulcers in patients with decreased perfusion, the
      sensor needs to be evaluated for extended periods of time.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2014</start_date>
  <completion_date type="Actual">September 2016</completion_date>
  <primary_completion_date type="Actual">July 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Accuracy as Indicated by Co-oximetry Measure of Arterial Oxygen Saturation</measure>
    <time_frame>24 hours</time_frame>
    <description>accuracy of sensor measure was defined as sensor measurements within 3% of co-oximetry measures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Device Related Pressure Ulcer</measure>
    <time_frame>5 days</time_frame>
    <description>assessment for development of pressure ulcer at forehead sensor, &quot;OxiMaxTM, Nellcor,Covidien&quot; and nasal alar sensor, &quot;Alar One-SenseTM, Xhale Assurance&quot;</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">43</enrollment>
  <condition>Hypotension</condition>
  <condition>Pressure Ulcer</condition>
  <arm_group>
    <arm_group_label>Nasal alar oxygen sensor</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Application of a nasal alar oxygen sensor</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal alar oxygen sensor</intervention_name>
    <description>Application of a nasal alar oxygen sensor</description>
    <arm_group_label>Nasal alar oxygen sensor</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        1. Presence of an existing arterial catheter for blood sampling and one of the following:

          1. Difficulty obtaining a consistent signal from a digit or ear sensor or

          2. On pressors of at least 0 .10 mcg/kg/min of norepinephrine or

          3. Core temperature &lt; or equal to 35 degrees C

        Exclusion Criteria:

          1. Anatomic impediments (burns, wounds, dressings, etc.) to placement of the sensor on
             the forehead or nasal alar

          2. History of known dyshemoglobinemias evidenced by carboxyhemoglobin levels &gt; 10% or
             methemoglobin level &gt; 2%

          3. Severe anemia with hemoglobin &lt; 5 g/dL

          4. Pregnant women
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marilyn E Schallom, RN, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Barnes-Jewish Hospital at Washington University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Barnes-Jewish Hospital at Washington University</name>
      <address>
        <city>Saint Louis</city>
        <state>Missouri</state>
        <zip>63110</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 10, 2015</study_first_submitted>
  <study_first_submitted_qc>March 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 6, 2015</study_first_posted>
  <results_first_submitted>February 20, 2017</results_first_submitted>
  <results_first_submitted_qc>May 8, 2017</results_first_submitted_qc>
  <results_first_posted type="Actual">June 7, 2017</results_first_posted>
  <last_update_submitted>May 8, 2017</last_update_submitted>
  <last_update_submitted_qc>May 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Washington University School of Medicine</investigator_affiliation>
    <investigator_full_name>Lynn Schallom</investigator_full_name>
    <investigator_title>Research Scientist</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
    <mesh_term>Hypotension</mesh_term>
    <mesh_term>Pressure Ulcer</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Nasal Alar Oxygen Sensor</title>
          <description>Application of a nasal alar oxygen sensor
Nasal alar oxygen sensor: Application of a nasal alar oxygen sensor</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>transfer out of ICU</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>arterial catheter loss</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>pressure injury both sites</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Nasal Alar Oxygen Sensor</title>
          <description>Application of a nasal alar oxygen sensor
Nasal alar oxygen sensor: Application of a nasal alar oxygen sensor</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="43"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="24"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.1" spread="16.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="26"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Accuracy as Indicated by Co-oximetry Measure of Arterial Oxygen Saturation</title>
        <description>accuracy of sensor measure was defined as sensor measurements within 3% of co-oximetry measures</description>
        <time_frame>24 hours</time_frame>
        <population>Nasal sensor unable to obtain a signal 7% of measures on enrollment, Forehead sensor unable to obtain signal 32% of measures on enrollment.</population>
        <group_list>
          <group group_id="O1">
            <title>Nasal Alar Oxygen Sensor</title>
            <description>Application of a nasal alar oxygen sensor
Nasal alar oxygen sensor: Application of a nasal alar oxygen sensor</description>
          </group>
        </group_list>
        <measure>
          <title>Accuracy as Indicated by Co-oximetry Measure of Arterial Oxygen Saturation</title>
          <description>accuracy of sensor measure was defined as sensor measurements within 3% of co-oximetry measures</description>
          <population>Nasal sensor unable to obtain a signal 7% of measures on enrollment, Forehead sensor unable to obtain signal 32% of measures on enrollment.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Device Related Pressure Ulcer</title>
        <description>assessment for development of pressure ulcer at forehead sensor, &quot;OxiMaxTM, Nellcor,Covidien&quot; and nasal alar sensor, &quot;Alar One-SenseTM, Xhale Assurance&quot;</description>
        <time_frame>5 days</time_frame>
        <population>incidence of any pressure injury</population>
        <group_list>
          <group group_id="O1">
            <title>Nasal Alar Oxygen Sensor</title>
            <description>Application of a nasal alar oxygen sensor
Nasal alar oxygen sensor: Application of a nasal alar oxygen sensor</description>
          </group>
        </group_list>
        <measure>
          <title>Device Related Pressure Ulcer</title>
          <description>assessment for development of pressure ulcer at forehead sensor, &quot;OxiMaxTM, Nellcor,Covidien&quot; and nasal alar sensor, &quot;Alar One-SenseTM, Xhale Assurance&quot;</description>
          <population>incidence of any pressure injury</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <non_inferiority_desc>comparing nasal and forehead oximetry sensor pressure ulcer incidence</non_inferiority_desc>
            <p_value>=.006</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Nasal Alar Oxygen Sensor</title>
          <description>Application of a nasal alar oxygen sensor
Nasal alar oxygen sensor: Application of a nasal alar oxygen sensor</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="22" subjects_at_risk="43"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>50% the patients expired after being placed on comfort care prior to final collection</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Marilyn Schallom</name_or_title>
      <organization>Barnes-Jewish Hospital</organization>
      <phone>314-286-0835</phone>
      <email>marilyn.schallom@bjc.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

